Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anaesthetic management of patients with diabetes mellitus.
McAnulty GR, Robertshaw HJ, Hall GM. McAnulty GR, et al. Among authors: robertshaw hj. Br J Anaesth. 2000 Jul;85(1):80-90. doi: 10.1093/bja/85.1.80. Br J Anaesth. 2000. PMID: 10927997 Free article. Review. No abstract available.
Diabetes mellitus: anaesthetic management.
Robertshaw HJ, Hall GM. Robertshaw HJ, et al. Anaesthesia. 2006 Dec;61(12):1187-90. doi: 10.1111/j.1365-2044.2006.04834.x. Anaesthesia. 2006. PMID: 17090240 Free article. Review.
Metalloproteinase-9 in critically patients.
Robertshaw HJ, Hall GM. Robertshaw HJ, et al. Anaesthesia. 2002 Jan;57(1):84-5. Anaesthesia. 2002. PMID: 11848064 Free article. No abstract available.
Strategies for managing the diabetic patient.
Robertshaw HJ, McAnulty GR, Hall GH. Robertshaw HJ, et al. Best Pract Res Clin Anaesthesiol. 2004 Dec;18(4):631-43. doi: 10.1016/j.bpa.2004.05.012. Best Pract Res Clin Anaesthesiol. 2004. PMID: 15460549 Review.
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y, Xu J, Levin J, Hegen M, Li G, Robertshaw H, Brennan F, Cummons T, Clarke D, Vansell N, Nickerson-Nutter C, Barone D, Mohler K, Black R, Skotnicki J, Gibbons J, Feldmann M, Frost P, Larsen G, Lin LL. Zhang Y, et al. J Pharmacol Exp Ther. 2004 Apr;309(1):348-55. doi: 10.1124/jpet.103.059675. Epub 2004 Jan 12. J Pharmacol Exp Ther. 2004. PMID: 14718605
14 results